News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
678,439 Results
Type
Article (38757)
Company Profile (247)
Press Release (639435)
Section
Business (203452)
Career Advice (1977)
Deals (35342)
Drug Delivery (78)
Drug Development (80588)
Employer Resources (167)
FDA (15996)
Job Trends (14777)
News (343574)
Policy (32405)
Tag
Academia (2528)
Africa (710)
Alliances (48958)
Alzheimer's disease (1137)
Approvals (15927)
Arizona (173)
Artificial intelligence (66)
Asia (36763)
Australia (5978)
Bankruptcy (350)
Best Places to Work (11253)
Biosimilars (63)
Biotechnology (173)
C2C Services and Suppliers (78801)
California (1757)
Canada (898)
Cancer (387)
Career advice (1647)
Cell therapy (111)
China (134)
Clinical research (63075)
Collaboration (125)
Colorado (69)
Compensation (71)
Connecticut (68)
COVID-19 (2482)
Cystic fibrosis (72)
Data (223)
Diabetes (79)
Diagnostics (5960)
Drug pricing (61)
Earnings (83632)
Employer resources (142)
Europe (78511)
Events (107670)
Executive appointments (132)
FDA (16192)
Florida (251)
Funding (131)
Gene therapy (87)
GLP-1 (505)
Government (4286)
Healthcare (18597)
Hotbed/Location (480970)
Illinois (245)
Indiana (142)
Infectious disease (2508)
Inflammatory bowel disease (88)
Interviews (306)
IPO (16182)
Job creations (3618)
Job search strategy (1412)
Kansas (94)
Layoffs (392)
Legal (7827)
Lung cancer (90)
Manufacturing (81)
Maryland (370)
Massachusetts (1437)
Medical device (13027)
Medtech (13032)
Mergers & acquisitions (19000)
Metabolic disorders (239)
Michigan (122)
Minnesota (210)
Neuroscience (1268)
New Jersey (532)
New York (557)
NextGen Class of 2024 (6479)
Non-profit (4454)
North Carolina (577)
Northern California (784)
Obesity (143)
Ohio (102)
Opinion (171)
Patents (65)
Pennsylvania (559)
People (55788)
Pharmaceutical (60)
Phase I (19536)
Phase II (27776)
Phase III (20762)
Pipeline (103)
Postmarket research (2546)
Preclinical (8305)
Press Release (64)
Rare diseases (125)
Real estate (5880)
Recruiting (63)
Regulatory (21159)
Research institute (2303)
Resumes & cover letters (346)
South America (1084)
Southern California (711)
Startups (3557)
Texas (220)
United States (8099)
Vaccines (461)
Washington State (242)
Weight loss (124)
Date
Today (131)
Last 7 days (608)
Last 30 days (2234)
Last 365 days (37204)
2024 (25541)
2023 (40074)
2022 (51173)
2021 (55713)
2020 (54087)
2019 (46541)
2018 (35020)
2017 (32111)
2016 (31480)
2015 (37552)
2014 (31318)
2013 (26346)
2012 (28570)
2011 (29263)
2010 (27328)
678,439 Results for "vgxi inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
VGXI Inc. announces a strategic partnership with Sutro Biopharma Inc. to support growing clinical pipeline
VGXI, Inc. has entered into a strategic partnership with Sutro Biopharma, Inc. to support clinical production of luveltamab tazevibulin, abbreviated as “luvelta”, a novel Folate Receptor-α -targeting antibody-drug conjugate with the potential to address the unmet need in several FRα-expressing cancers.
June 3, 2024
·
4 min read
Business
Stephanie Burke Named as VGXI’s New Chief Accounting Officer
VGXI, Inc., a leading contract developer and manufacturer specializing in nucleic acid biopharmaceuticals, including gene therapies, DNA vaccines, and RNA medicines, is pleased to announce the appointment of Stephanie Burke as the Chief Accounting Officer for VGXI.
March 27, 2024
·
3 min read
Business
VGXI Welcomes Michael Stewart as New Chief Operating Officer
VGXI, Inc., a leading contract developer and manufacturer specializing in nucleic acid biopharmaceuticals, including gene therapies, DNA vaccines, and RNA medicines, proudly announces the appointment of Michael Stewart as its new Chief Operating Officer.
March 4, 2024
·
3 min read
Business
VGXI Announces Strategic Multi-Year Partnership with Resilience to Accelerate Biomanufacturing of Advanced Medicines
VGXI, Inc. have entered a strategic multi-year partnership.
January 24, 2024
·
3 min read
Drug Development
Our Mission at Voyager Therapeutics: Define the Future of Neurogenetic Medicines
We are in an unprecedented time in neurotherapeutics. Medicines that address the causative disease biology underlying central nervous system
May 8, 2024
·
2 min read
·
Voyager Therapeutics, Inc.
Press Releases
Verrica Pharmaceuticals Announces Litigation Settlement with Dormer Laboratories, Inc.
Verrica Pharmaceuticals Inc. today announced the settlement of litigation with Dormer Laboratories, Inc. (“Dormer Labs”).
July 1, 2024
·
5 min read
Lophos Holdings Inc. Announces the Completion of Securities Purchase Agreement with ThreeD Capital Inc.
Lophos Holdings Inc. (CSE: MESC) (“Lophos” or the “Company”), a Canadian bioscience company focused on the cultivation and sale of Lophophora williamsii (“Peyote”) and ThreeD Capital Inc. (CSE: IDK) (OTCQB: IDKFF) (“ThreeD”), a Canadian-based venture capital firm focused on opportunistic investments in companies in the junior resources and disruptive technologies sectors, are pleased to announce the completion of its previously announced Securities Purchase Agreement (the “Agreement”).
June 20, 2024
·
4 min read
Vivos Inc. Submits the Application to the FDA for Authority to Initiate Human Clinical Trials
Vivos Inc. (OTCQB: RDGL), Vivos Inc. filed the application for an Investigational Device Exemption (“IDE”).
June 28, 2024
·
4 min read
Merit Medical Announces Asset Purchase Agreement with EndoGastric Solutions, Inc.®
Merit Medical Systems, Inc., a global leader of healthcare technology, announced it has executed an asset purchase agreement with EndoGastric Solutions, Inc. for a total cash consideration of approximately $105 million.
July 1, 2024
·
18 min read
Press Releases
ReCerise Therapeutics Inc. Selected for Government Project by MOTIE
Initiates Development of Tailored Innovative Targeted Therapy for Refractory Cancer ReCerise Therapeutics Inc., has announced its selection for a grant from the Ministry of Trade, Industry and Energy of South Korea.
July 1, 2024
·
2 min read
1 of 67,844
Next